PLD2 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant PLD2.
- CITATIONS: 3
|Application ||WB, E|
|Calculated MW||105987 Da|
|Other Names||Phospholipase D2, PLD 2, hPLD2, Choline phosphatase 2, PLD1C, Phosphatidylcholine-hydrolyzing phospholipase D2, PLD2|
|Target/Specificity||PLD2 (AAH15033, 834 a.a. ~ 933 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||PLD2 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Provided below are standard protocols that you may find useful for product applications.
Phosphatidylcholine (PC)-specific phospholipases D (PLDs; EC 188.8.131.52) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.
1.Construction of lentiviral shRNA expression vector targeting phospholipase D2 (PLD2) gene??.Lian XF, Yu CX, He XL, Lin JJ, Chen YZ, Zhu L.African Journal of Biotechnology Vol. 10 (66), pp. 15044-15050, 26 October, 20112.Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.Somers-Edgar TJ, Taurin S, Larsen L, Chandramouli A, Nelson MA, Rosengren RJ.Invest New Drugs. 2009 Oct 9. [Epub ahead of print]
If you have any additional inquiries please email technical services at firstname.lastname@example.org.